Inmune Stock Price History Breakdown

INMB
 Stock
  

USD 6.42  0.29  4.73%   

As of today, the current price of Inmune Bio is  6.42 , as last reported on the 5th of October, with the highest price reaching  6.70  and the lowest price hitting  6.24  during the day.
Inmune Bio holds Efficiency (Sharpe) Ratio of -0.16, which attests that the entity had -0.16% of return per unit of risk over the last 3 months. Macroaxis standpoint towards determining the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Inmune Bio exposes twenty-eight different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to check out Inmune Bio risk adjusted performance of (0.11), and Market Risk Adjusted Performance of (0.24) to validate the risk estimate we provide.
  

Inmune Bio October 5, 2022 Stock Price Synopsis

Inmune Bio Price Daily Balance Of Power 0.63 
Inmune Bio Price Rate Of Daily Change 1.05 
Inmune Bio Accumulation Distribution 5,712 
Inmune Bio Price Action Indicator 0.09 

Inmune Bio October 5, 2022 Stock Price Analysis

Share Download
When benchmark price declines in a down market, there may be an uptick in Inmune Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Inmune Bio intraday prices and daily technical indicators to check the level of noise trading in Inmune Stock and then apply it to test your longer-term investment strategies against Inmune.

Inmune Bio Stock Price History Chart

There are several ways to analyze Inmune Stock price data. The simplest method is using a basic Inmune candlestick price chart, which shows Inmune Bio price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

90 Days Highest PriceJuly 13, 202210.44
90 Days Lowest PriceSeptember 27, 20226.04

Inmune Stock Price History Data

The price series of Inmune Bio for the period between Thu, Jul 7, 2022 and Wed, Oct 5, 2022 has a statistical range of 4.4 with a coefficient of variation of 13.42. Under current investment horizon, the daily prices are spread out with arithmetic mean of 8.7. The median price for the last 90 days is 8.92.
OpenHighLowCloseVolume
10/05/2022 6.25  6.70  6.24  6.42  83,200 
10/04/2022 6.25  6.70  6.25  6.42  83,219 
10/03/2022 6.39  6.39  6.03  6.13  36,459 
09/30/2022 6.40  6.64  6.15  6.20  52,287 
09/29/2022 6.63  6.69  6.15  6.23  45,944 
09/28/2022 6.34  6.94  6.34  6.65  65,300 
09/27/2022 6.38  6.49  6.04  6.04  40,116 
09/26/2022 7.07  7.05  6.32  6.37  69,206 
09/23/2022 7.56  7.56  6.90  6.91  56,224 
09/22/2022 7.64  7.81  7.45  7.70  75,815 
09/21/2022 7.75  7.90  7.65  7.83  89,192 
09/20/2022 7.78  7.88  7.31  7.61  58,021 
09/19/2022 7.85  7.91  7.06  7.80  150,182 
09/16/2022 8.09  8.38  7.28  7.84  108,529 
09/15/2022 8.42  8.55  8.16  8.20  31,199 
09/14/2022 8.43  8.54  8.04  8.40  35,026 
09/13/2022 8.20  8.53  8.07  8.34  41,459 
09/12/2022 8.28  8.49  8.03  8.39  30,881 
09/09/2022 8.31  8.70  8.03  8.27  56,064 
09/08/2022 7.96  8.25  7.94  8.17  37,736 
09/07/2022 7.72  8.29  7.56  8.15  56,300 
09/06/2022 8.26  8.26  7.60  7.66  30,500 
09/02/2022 8.26  8.34  8.06  8.15  33,003 
09/01/2022 7.70  8.13  7.70  8.13  31,819 
08/31/2022 8.50  8.69  7.64  8.07  100,486 
08/30/2022 8.45  8.69  8.40  8.43  19,648 
08/29/2022 8.32  8.69  8.27  8.45  23,093 
08/26/2022 9.00  9.00  8.21  8.33  39,070 
08/25/2022 8.97  9.09  8.77  8.92  40,800 
08/24/2022 8.64  8.98  8.53  8.73  58,187 
08/23/2022 8.32  8.66  8.25  8.56  71,374 
08/22/2022 8.59  8.75  8.28  8.34  53,880 
08/19/2022 8.78  9.04  8.71  8.76  39,647 
08/18/2022 9.16  9.28  8.90  9.02  43,108 
08/17/2022 9.17  9.42  9.00  9.08  38,792 
08/16/2022 9.10  9.70  9.02  9.40  56,446 
08/15/2022 9.22  9.44  8.94  9.17  80,180 
08/12/2022 9.24  9.48  9.21  9.41  25,143 
08/11/2022 9.38  9.74  9.05  9.12  39,752 
08/10/2022 9.51  9.59  9.22  9.33  27,855 
08/09/2022 9.95  10.10  9.12  9.30  57,811 
08/08/2022 10.39  10.57  9.82  10.16  92,368 
08/05/2022 10.15  10.75  9.99  10.39  83,900 
08/04/2022 9.71  10.37  9.50  10.31  55,148 
08/03/2022 9.90  10.39  9.90  10.05  64,300 
08/02/2022 9.01  9.72  8.95  9.71  98,700 
08/01/2022 9.15  9.29  8.92  9.03  39,000 
07/29/2022 9.00  9.17  8.80  8.97  45,852 
07/28/2022 9.20  9.26  8.90  9.13  34,799 
07/27/2022 8.80  9.29  8.53  9.22  32,546 
07/26/2022 8.78  9.20  8.65  8.80  50,591 
07/25/2022 9.24  9.39  8.73  8.93  104,358 
07/22/2022 10.06  10.06  9.10  9.33  60,900 
07/21/2022 10.16  10.20  9.73  9.99  38,557 
07/20/2022 9.88  10.44  9.80  10.10  36,052 
07/19/2022 9.81  10.24  9.81  9.99  37,711 
07/18/2022 10.38  10.41  9.61  9.68  62,250 
07/15/2022 9.88  10.26  9.61  10.24  39,889 
07/14/2022 10.50  10.50  9.79  9.86  157,542 
07/13/2022 9.79  10.47  9.66  10.44  32,118 
07/12/2022 10.13  10.22  9.33  10.14  112,834 

About Inmune Bio Stock history

Inmune Bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Inmune is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Inmune Bio will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Inmune Bio historical stock prices may prove useful in developing a viable investing in Inmune Bio
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patients innate immune system to treat disease. INmune Bio, Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida. Inmune Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 10 people.

Inmune Bio Stock Technical Analysis

Inmune Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Inmune Bio technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Inmune Bio trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Equity Analysis Now

   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Module

Inmune Bio Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Inmune stock's direction in advance. Along with the technical and fundamental analysis of Inmune Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Inmune to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen stock market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Please see Risk vs Return Analysis. You can also try Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for analysis

When running Inmune Bio price analysis, check to measure Inmune Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inmune Bio is operating at the current time. Most of Inmune Bio's value examination focuses on studying past and present price action to predict the probability of Inmune Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Inmune Bio's price. Additionally, you may evaluate how the addition of Inmune Bio to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Is Inmune Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inmune Bio. If investors know Inmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inmune Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Inmune Bio is measured differently than its book value, which is the value of Inmune that is recorded on the company's balance sheet. Investors also form their own opinion of Inmune Bio's value that differs from its market value or its book value, called intrinsic value, which is Inmune Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inmune Bio's market value can be influenced by many factors that don't directly affect Inmune Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inmune Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Inmune Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inmune Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.